We are excited to announce new funding from the National Cancer Institute. This 5-year grant supports our studies on the tumor microenvironment, specifically hypoxia, in triple negative breast cancer (TNBC). Hypoxia is a major cause of resistance to therapies. Thus, we hope to identify mechanisms to suppress the hypoxia stress response and reveal new paths to sensitize TNBC tumors to therapy. Please contact us if you are interested in post-doc opportunities! Candidates with expertise in bioinformatics are particularly encouraged to apply.
Learn more:
https://reporter.nih.gov/search/Svw3JJPrsEO_uzzZkDKoDA/project-details/10520756
ROSNER LABORATORY 